ec-18
Small moleculeexperimental
Clinical trial activity
8 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02532712)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ec-18
- ec-18
- ec-18
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06487000 | Phase 2 | May 31, 2025 | Enzychem Lifesciences |
| NCT04569227 | Phase 2 | Nov 16, 2020 | Enzychem Lifesciences |
| NCT04500132 | Phase 2 | May 28, 2020 | Chonbuk National University, Enzychem Lifesciences |
| NCT03200340 | Phase 2 | Jan 1, 2018 | Enzychem Lifesciences, Exsulin Corporation |
| NCT03104595 | Phase 2 | Jun 1, 2017 | Enzychem Lifesciences |
| NCT02700360 | Phase 1 | Aug 1, 2015 | Enzychem Lifesciences, Yonsei University |
| NCT02496143 | Phase 1 | Jul 1, 2015 | Enzychem Lifesciences, Wake Research Associates |
| NCT02532712 | Phase 1 | Mar 1, 2015 | Enzychem Lifesciences, Yonsei University |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Enzychem Lifesciences | For profit | 8 | 8 | 2 | 2015 |
| Yonsei University | Academic/Hospital | 2 | 0 | 1 | 2015 |
| Chonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Exsulin Corporation | For profit | 1 | 0 | 1 | 2018 |
| Wake Research Associates | For profit | 1 | 0 | 1 | 2015 |
5 organizations
Page 1 / 1